InvestorsObserver
×
News Home

Do Analysts Expect Pfizer Inc. (PFE) Stock to Rise After It Has Risen 7.52% in a Month?

Monday, December 05, 2022 10:25 AM | InvestorsObserver Analysts

Mentioned in this article

Do Analysts Expect Pfizer Inc. (PFE) Stock to Rise After It Has Risen 7.52% in a Month?

InvestorsObserver is giving Pfizer Inc. (PFE) an Analyst Rating Rank of 51, meaning PFE is ranked higher by analysts than 51% of stocks. The average price target for PFE is $57.09 and analyst’s rate the stock as a Strong Buy.

Overall Score - 4.3
Wall Street analysts are rating PFE a Strong Buy today. Find out what this means to you and get the rest of the rankings on PFE!

Why are Analyst Ratings Important?

Though analyst projections should not be your only resource when determining your position on a stock, it can be a very useful tool. Analysts follow sectors/industries in-depth and tend to know how local and global conditions tend to affect demand and prices. Many analysts even participate in conference calls where they can get information to better make sense of the numbers. InvestorsObserver averages the ratings provided by analysts and then ranks their score as a percent against the market. This allows you to compare stocks in a more comprehensive fashion than with the typical buy/sell/hold ranking.

What's Happening With Pfizer Inc. Stock Today?

Pfizer Inc. (PFE) stock is trading at $50.63 as of 10:11 AM on Monday, Dec 5, a loss of -$0.28, or -0.55% from the previous closing price of $50.91. The stock has traded between $50.42 and $51.03 so far today. Volume today is below average. So far 2,174,567 shares have traded compared to average volume of 21,466,010 shares. Click Here to get the full Stock Report for Pfizer Inc. stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App